ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data ICI Tx in MS Patients With Comorbid Cancer: Reassuring Data
There is no increased relapse risk in patients with multiple sclerosis and comorbid cancer who are taking checkpoint inhibitor therapy, results of a small study suggest.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Neurology & Neurosurgery News Source Type: news
More News: Brain | Cancer | Cancer & Oncology | Hematology | Multiple Sclerosis | Neurology | Neurosurgery | Study